diffuse large b cell lymphoma

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Toripalimab, Rituximab
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
    Department of hematology department, Nanfang hospital
Apr 6, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Camrelizumab,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 10, 2021

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
  • Beijing, Beijing, China
  • +9 more
Jan 17, 2021

Clinical Decision-making in Diffuse Large B-Cell Lymphoma in

Unknown status
  • Diffuse Large B Cell Lymphoma
    • Guangzhou, Guangdong, China
    • +2 more
    Nov 6, 2020

    Diffuse Large B Cell Lymphoma, Age Over 80 Years Trial in Guangzhou (lenalidomide combined with rituximab)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Age Over 80 Years
    • lenalidomide combined with rituximab
    • Guangzhou, Guangdong, China
      Guangdong provincial people's hospital
    Nov 5, 2020

    Diffuse Large B Cell Lymphoma Trial in Guangzhou (Lenalidomide)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Guangzhou, Guangdong, China
      Nanfang hospital
    Sep 3, 2020

    Diffuse Large B Cell Lymphoma Trial in Guangzhou (CHOP combined with CMAB304, CHOP, CMAB304)

    Completed
    • Diffuse Large B Cell Lymphoma
    • CHOP combined with CMAB304
    • CHOP, CMAB304
    • Guangzhou, Guangdong, China
      SUN-YAT-SEN university cancer center
    Oct 25, 2011